Free Trial

Hepion Pharmaceuticals (HEPA) SEC Filings & 10K Form

Hepion Pharmaceuticals logo
$0.62 -0.06 (-8.82%)
(As of 10:20 AM ET)

Recent Hepion Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/14/2024
3:52 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/05/2024
5:36 AM
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form 425
09/05/2024
5:15 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
8:04 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
8:08 AM
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form 425
07/22/2024
7:33 AM
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form 425
07/22/2024
7:28 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
11:15 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form EFFECT
07/15/2024
4:17 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 424B3
07/11/2024
8:46 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/24/2024
6:07 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-K/A
05/21/2024
4:08 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
3:46 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form NT 10-Q
04/16/2024
3:53 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
3:30 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form NT 10-K
03/06/2024
3:30 PM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Purcell Michael J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/06/2024
3:15 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
7:01 PM
BRANCACCIO JOHN P (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:01 PM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Lbiati Kaouthar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:01 PM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
JACOB GARY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:01 PM
Block Timothy M. (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
8:02 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:38 PM
ARMISTICE CAPITAL, LLC (Filed by)
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form SC 13G
01/03/2024
3:30 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
7:41 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
5:55 AM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Wijngaard Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HEPA) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners